A theme covering the ongoing expansion and rationalization of pharmaceutical production and R&D facilities, including production buildings for APIs and finished dosage forms, packaging buildings, testing buildings, and industrialization process research buildings. It also covers capacity expansions at multiple sites, including Chinese subsidiaries.